Screening by mammography, women with a family history of breast cancer

European Journal of Cancer

Volumn 34, Issue 6, 1998, Pages 937-940

  Lalloo, F ^a   Boggis, C R M ^b   Evans, D G R ^a   Shenton, A ^a   Threlfall, A G ^a   Howell, A ^a  

^a CHRISTIE HOSPITAL   (United Kingdom)

^b WITHINGTON HOSPITAL   (United Kingdom)

Author keywords

Breast cancer; Genetics; High risk women; Screening (mammography)

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER INVASION; CANCER RISK; CANCER SCREENING; FAMILY HISTORY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MAMMOGRAPHY; PRIORITY JOURNAL;

ADULT; BREAST NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; PEDIGREE; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 0032078898     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(98)00005-7     Document Type: Article

References (17)

1. Peto J, Easton DF, Matthews FE, Ford D, Swerdlow AJ. Cancer mortality in relatives of women with breast cancer: the OPCS study. IntJ Cancer 1996, 65, 275-283.
2. Claus EB, Risch N, Thompson WD. Genetic analysis of breast cancer in the cancer and steroid hormone study. Am J Hum Genet 1991,48, 232-242.
3. Easton DF, Ford D, Bishop DT. Breast Cancer Linkage Consortium, breast and ovarian cancer incidence in BRCA1-mutation carriers. Am J Hum Genet 1995, 56, 265-271.
4. Claus EB, Risch N, Thompson WD. Autosomal dominant inheritance of early-onset breast cancer; implications for risk prediction. Cancer 1994, 73, 643-651.
5. Patnick J, ed. NHS breast screening programme review 1994. Sheffield: National Health Service Breast Screening Programme, 1994, 16-18.
6. Frykberg ER, Bland KI. Overview of the biology and management of ductal carcinoma in situ of the breast. Cancer 1994, 74, 350-361.
7. Weiss HA, Brinton LA, Brogan D, Coates RJ, Gammon MD, Malone KE, et al. Epidemiology of in situ and invasive breast cancer in women aged under 45. Br J Cancer 1996 73, 1298-1305.
8. Kerlikowske K, Barclay J, Grady D, Sickles EA, Ernster V. Comparison of risk factors for ductal carcinoma in situ and invasive breast cancer. J Natl Cancer Inst 1997, 89, 76-82.
9. Claus EB, Risch N, Thompson WD, Carter D. Relationship between breast histopathology and family history of breast cancer. Cancer 1993, 71, 147-153.
10. Lampejo OT, Barnes DM, Smith P, Millis RR. Evaluation of infiltrating ductal carcinomas with a DCIS component: correlation of the in-situ component with grade of infiltrating component. Seminars in DiagPath 1994, 11, 215-222.
11. Woodman CBJ, Singleton J, Coyne J, Baildam A. Management of premenopausal women with primary breast cancer. Br J Surg 1996,83, 1256-1257.
12. Breast Cancer Linkage Consortium. Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Lancet 1997, 349, 1505-1510.
13. Kelsell DP, Spurr NK, Barnes DM, Gusterson B, Bishop DT. Combined loss of BRCA1/BRCA2 in grade 3 breast carcinomas. Lancet 1996,347, 1554-1555.
14. Eisinger F, Stoppa-Lyonnet D, Longy M, Kerangueven F, Noguchi T, Bailly C, et al. Germline mutation at BRCA1 affects the histoprognostic grade in hereditary breast cancer. Cancer Res 1996, 56, 471-474.
15. Marcus JN, Watson P, Page DL. Hereditary breast cancer. Pathobiology, prognosis and BRCA1 and BRCA2 linkage. Cancer 1996, 77, 697-709.
16. Organizing Committee and Collaborators, Falun Meeting, Falun, Sweden. Breast cancer screening with mammography in women aged 40-49 years: report of the organising committee and collaborators. Int J Cancer 1996, 68, 693-699.
17. Houlston RS, Lemoine L, McCarter E, Harrington S, MacDermor K, Hinton J, et al. Screening and genetic counselling for relatives of patients with breast cancer in a family cancer clinic. J Med Genet 1992, 29, 691-694.